Reuters logo
India Dr Reddy's gets FDA nod for osteoporosis drug
August 11, 2008 / 3:05 AM / 9 years ago

India Dr Reddy's gets FDA nod for osteoporosis drug

MUMBAI, Aug 11 (Reuters) - Indian drugmaker Dr. Reddy’s Laboratories Ltd (REDY.BO) (RDY.N) has received approval from the U.S. Federal Drug Administration to make and market alendronate sodium tablets, the regulator’s website showed.

The drug, a generic version of Merck’s (MRK.N) Fosamax tablets, is indicated in the treatment of osteoporosis. (Reporting by Rina Chandran; Editing by Ranjit Gangadharan)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below